1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH harmonised tripartite guideline E14: the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs International Conference on Harmonisation 2005 http://www.ich.org/LOB/media/MEDIA1476.pdf
2. International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH harmonised tripartite guideline S7B: the nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals International Conference on Harmonisation 2005 http://www.ich.org/LOB/media/MEDIA2192.pdf
3. Pharmacokinetic and pharmacodynamic characterization of non-antiarrhythmic QT-prolonging drugs associated with Torsades de Pointes;Lin;Drug Inf J,2008
4. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes;De Ponti;Drug Saf,2002
5. Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes;Owens;Pharmacotherapy,2001